Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of ProPhase Labs Inc (NASDAQ: PRPH) was $0.37 for the day, up 4.29% from the previous closing price of $0.35. In other words, the price has increased by $4.29 from its previous closing price. On the day, 0.83 million shares were traded.
Ratios:
Our analysis of PRPH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 20, 2021, initiated with a Buy rating and assigned the stock a target price of $12.
On January 20, 2021, Dawson James started tracking the stock assigning a Buy rating and target price of $25.Dawson James initiated its Buy rating on January 20, 2021, with a $25 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.19 while its Price-to-Book (P/B) ratio in mrq is 0.97.
Stock Price History:
Over the past 52 weeks, PRPH has reached a high of $5.22, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 7.10%, while the 200-Day Moving Average is calculated to be -66.67%.
Shares Statistics:
A total of 41.54M shares are outstanding, with a floating share count of 36.67M. Insiders hold about 11.73% of the company’s shares, while institutions hold 12.02% stake in the company.
